Abstract
CD8 T cells specific for islet autoantigens are major effectors of β cell damage in type 1 diabetes, and measurement of their number and functional characteristics in blood represent potentially important disease biomarkers. CD8 T cell reactivity against glutamic acid decarboxylase 65 (GAD65) in HLA-A*0201 subjects has been reported to focus on an immunogenic region 114-123 (VMNILLQYVV), with studies demonstrating both 114-123 and 114-122 epitopes being targeted. However, the fine specificity of this response is unclear and the key question as to which epitope(s) β cells naturally process and present and, therefore, the pathogenic potential of CD8 T cells with different specificities within this region has not been addressed. We generated human leucocyte antigen (HLA)-A*0201-restricted CD8 T cell clones recognizing either 114-122 alone or both 114-122 and 114-123. Both clone types show potent and comparable effector functions (cytokine and chemokine secretion) and killing of indicator target cells externally pulsed with cognate peptide. However, only clones recognizing 114-123 kill target cells transfected with HLA-A*0201 and GAD2 and HLA-A*0201(+) human islet cells. We conclude that the endogenous pathway of antigen processing by HLA-A*0201-expressing cells generates GAD65114-123 as the predominant epitope in this region. These studies highlight the importance of understanding β cell epitope presentation in the design of immune monitoring for potentially pathogenic CD8 T cells.
Original language | English |
---|---|
Pages (from-to) | 100-107 |
Number of pages | 8 |
Journal | Clinical and Experimental Immunology |
Volume | 179 |
Issue number | 1 |
Early online date | 26 Nov 2014 |
DOIs | |
Publication status | Published - Jan 2015 |
Keywords
- autoimmunity
- CD8 T cell clones
- GAD65
- peptide-processing
- type 1 diabetes
- KILL BETA-CELLS
- EPITOPES
- MHC
- SUSCEPTIBILITY
- IDENTIFICATION
- TETRAMERS
- DATABASE
- ONSET